Today's announcement of 10,000 jobs cut in Pfizer does not seem to have made much of an impact on its stocks. What gives? If anything, I would've thought that this layoff would boost the stock price as the investors would see that the company is making positive moves towards being competitive. Maybe it is too soon to tell. With P/E ratio of only 16, I would say Pfizer stocks are on sale. So is Wyeth with P/E ratio of 18. And according to Motly Fool report, Novartis has good number of drugs in the pipeline. Its P/E ratio is 20. What do you say? Should I buy some of these stocks?